1. Home
  2. NVOS vs MTEM Comparison

NVOS vs MTEM Comparison

Compare NVOS & MTEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVOS
  • MTEM
  • Stock Information
  • Founded
  • NVOS 2000
  • MTEM N/A
  • Country
  • NVOS United States
  • MTEM United States
  • Employees
  • NVOS N/A
  • MTEM N/A
  • Industry
  • NVOS Assisted Living Services
  • MTEM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NVOS Health Care
  • MTEM Health Care
  • Exchange
  • NVOS Nasdaq
  • MTEM Nasdaq
  • Market Cap
  • NVOS 9.9M
  • MTEM 8.5M
  • IPO Year
  • NVOS 2017
  • MTEM N/A
  • Fundamental
  • Price
  • NVOS $0.53
  • MTEM $1.38
  • Analyst Decision
  • NVOS
  • MTEM
  • Analyst Count
  • NVOS 0
  • MTEM 0
  • Target Price
  • NVOS N/A
  • MTEM N/A
  • AVG Volume (30 Days)
  • NVOS 1.3M
  • MTEM 37.2K
  • Earning Date
  • NVOS 07-23-2024
  • MTEM 08-08-2024
  • Dividend Yield
  • NVOS N/A
  • MTEM N/A
  • EPS Growth
  • NVOS N/A
  • MTEM N/A
  • EPS
  • NVOS N/A
  • MTEM N/A
  • Revenue
  • NVOS $13,658,040.00
  • MTEM $31,763,000.00
  • Revenue This Year
  • NVOS N/A
  • MTEM N/A
  • Revenue Next Year
  • NVOS N/A
  • MTEM N/A
  • P/E Ratio
  • NVOS N/A
  • MTEM N/A
  • Revenue Growth
  • NVOS 16.91
  • MTEM N/A
  • 52 Week Low
  • NVOS $0.42
  • MTEM $1.01
  • 52 Week High
  • NVOS $5.38
  • MTEM $9.45
  • Technical
  • Relative Strength Index (RSI)
  • NVOS 37.41
  • MTEM 58.82
  • Support Level
  • NVOS $0.44
  • MTEM $1.26
  • Resistance Level
  • NVOS $0.79
  • MTEM $1.28
  • Average True Range (ATR)
  • NVOS 0.09
  • MTEM 0.10
  • MACD
  • NVOS -0.04
  • MTEM 0.04
  • Stochastic Oscillator
  • NVOS 20.93
  • MTEM 100.00

About NVOS Novo Integrated Sciences Inc.

Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.

About MTEM Molecular Templates Inc.

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

Share on Social Networks: